De Kang

Chinese Academy Of Medical Sciences And Peking Union Medical College, Xian Nong Tan Street
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum: Multi-protection of DL0410 in ameliorating cognitive defects in D-galactose induced aging mice.

Corrigendum: Multi-protection of DL0410 in ameliorating cognitive defects in D-galactose induced aging mice.

Journal: Frontiers in aging neuroscience

Published: April 19, 2024

Flubendazole suppresses VEGF-induced angiogenesis in HUVECs and exerts antitumor effects in PC-3 cells.

Flubendazole suppresses VEGF-induced angiogenesis in HUVECs and exerts antitumor effects in PC-3 cells.

Journal: Chemical biology & drug design

Published: August 23, 2023

Identification of multi-target anti-cancer agents from TCM formula by in silico prediction and in vitro validation.

Identification of multi-target anti-cancer agents from TCM formula by in silico prediction and in vitro validation.

Journal: Chinese journal of natural medicines

Published: December 16, 2021

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.

Journal: Pharmacology & therapeutics

Published: October 23, 2018

Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches.

Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches.

Journal: Oxidative medicine and cellular longevity

Published: February 15, 2018

Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist.

Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist.

Journal: Molecular medicine reports

Published: December 15, 2017

Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches.

Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches.

Journal: RSC advances

Published: November 09, 2017

Members of FOX family could be drug targets of cancers.

Members of FOX family could be drug targets of cancers.

Journal: Pharmacology & therapeutics

Published: August 24, 2017

Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.

Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.

Journal: Molecules (Basel, Switzerland)

Published: July 05, 2017

Multi-Protection of DL0410 in Ameliorating Cognitive Defects in D-Galactose Induced Aging Mice.

Multi-Protection of DL0410 in Ameliorating Cognitive Defects in D-Galactose Induced Aging Mice.

Journal: Frontiers in aging neuroscience

Published: June 30, 2017

The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

Journal: BioMed research international

Published: May 25, 2017

Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease.

Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease.

Journal: Chinese journal of natural medicines

Published: May 08, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026